A detailed history of Gamma Investing LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 148 shares of VYGR stock, worth $855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148
Previous 188 21.28%
Holding current value
$855
Previous $1.49 Million 41.76%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$5.77 - $9.27 $230 - $370
-40 Reduced 21.28%
148 $866,000
Q2 2024

Jul 02, 2024

SELL
$7.42 - $10.54 $81 - $115
-11 Reduced 5.53%
188 $1.49 Million
Q1 2024

Apr 05, 2024

BUY
$7.15 - $10.84 $357 - $542
50 Added 33.56%
199 $1.85 Million
Q4 2023

Feb 01, 2024

BUY
$6.28 - $8.81 $935 - $1,312
149 New
149 $1.08 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.